Publicaciones

Página 4 de 15

 

Año Título Autores

2017

Changing paradigms in Aedes control: considering the spatial heterogeneity of disease transmission

Vanlerberghe V; Go?mez-Dante?s H; Vazquez-Prokopec G; Alexander N; Manrique-Saide P; Coelho G; Toledo ME; Ocampo CB; Stuyft P Van der; DENTARGET network*

2017

The epidemiology of carbapenemases in Latin America and the Caribbean

Escandón-Vargas K; Reyes S; Gutiérrez S; Villegas MV.

2017

Pharmacokinetics of miltefosine in children and adults with cutaneous leishmaniasis

Castro MM; Gómez MA; Kip A; Cossio A; Ortíz E; Navas A; Dorlo T; Saravia NG.

2017

Local delivery of the Toll-Like Receptor 9 ligand CpG downregulates host immune and inflammatory responses, ameliorating established Leishmania (Viannia) panamensis Chronic Infection

Ehrlich AK; Fernandez O; Rodriguez-Pinto D; Castilho TM; Corral-Caridad MJ; Goldsmith-Pestana K; Saravia NG; McMahon-Pratt D.

2017

Epidemiology of candida isolates from Intensive Care Units in Colombia from 2010 to 2013

Motoa G; Muñoz JS; Oñate J; Pallares CJ; Hernandez C; Villegas MV.

2017

Screening of TNF?, IL-10 and TLR4 single nucleotide polymorphisms in individuals with asymptomatic and chronic cutaneous leishmaniasis in Colombia: A pilot study

Mera-Ramírez A; Castillo A; Orobio Y; Gómez MA; Gallego-Marin C.

2017

Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis

Berger BA; Cossio A; Saravia NG; Castro MM; Prada S; Bartlett AH; Pho MT.

2017

Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: a cohort study

Castro MM; Cossio A; Osorio L.

2017

Improved outcomes when antibiotic prescribing guidelines are followed by healthcare providers: A Colombian example to encourage adherence in hospital settings

Feinstein M; Escandón-Vargas K; Reyes S; Hernández-Gómez C; Pallares CJ; Villegas MV.

2017

A secondary wave of neutrophil infiltration causes necrosis and ulceration in lesions of experimental American cutaneous leishmaniasis

Peniche AG; Bonilla DL; Palma GI; Melby PC; Travi BL; Osorio EY.